[go: up one dir, main page]

MX9705324A - Sistema terapeutico transdermal para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmaceuticamente aptas. - Google Patents

Sistema terapeutico transdermal para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmaceuticamente aptas.

Info

Publication number
MX9705324A
MX9705324A MX9705324A MX9705324A MX9705324A MX 9705324 A MX9705324 A MX 9705324A MX 9705324 A MX9705324 A MX 9705324A MX 9705324 A MX9705324 A MX 9705324A MX 9705324 A MX9705324 A MX 9705324A
Authority
MX
Mexico
Prior art keywords
methyl
pyrrolidenyl
isoxazole
dispensing
pharmaceutically acceptable
Prior art date
Application number
MX9705324A
Other languages
English (en)
Other versions
MXPA97005324A (es
Inventor
Hanshermann Franke
Gerd Hoffmann
Heinrich Kindel
Stephen Peter Arneric
James Patrick Sullivan
John Burns Cannon
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX9705324A publication Critical patent/MX9705324A/es
Publication of MXPA97005324A publication Critical patent/MXPA97005324A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Una forma de aplicacion para el sustrato de (s)-3-mietl-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmacéuticamente aptas está caracterizada en que es un sistema terapéutico transdermal que tiene la forma de un emplasto.
MXPA/A/1997/005324A 1995-01-14 1997-07-14 Sistema terapeutico transdermal para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmaceuticamente aptas MXPA97005324A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19501022.1 1995-01-14
DE19501022A DE19501022C1 (de) 1995-01-14 1995-01-14 Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung
PCT/EP1996/000074 WO1996021434A1 (de) 1995-01-14 1996-01-10 Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze

Publications (2)

Publication Number Publication Date
MX9705324A true MX9705324A (es) 1997-10-31
MXPA97005324A MXPA97005324A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
AR001070A1 (es) 1997-09-24
BR9607488A (pt) 1997-12-23
IL116615A (en) 1999-09-22
DE59611212D1 (de) 2005-05-12
NZ298428A (en) 1999-10-28
EP0802790B1 (de) 2005-04-06
JPH10511972A (ja) 1998-11-17
DE19501022C1 (de) 1996-06-05
IL116615A0 (en) 1996-03-31
KR19980701419A (ko) 1998-05-15
EP0802790A1 (de) 1997-10-29
ATE292458T1 (de) 2005-04-15
WO1996021434A1 (de) 1996-07-18
CA2210341A1 (en) 1996-07-18
ZA96260B (en) 1996-08-01

Similar Documents

Publication Publication Date Title
GB2303064B (en) Medicament for nasal administration
AU4449789A (en) Delivery system for pharmaceutical or therapeutic actives
ZA962536B (en) Pharmaceutical composition for transdermal administration.
AU6060896A (en) Oral 1alpha-hydroxyprevitamin D
AU4399196A (en) Intravaginal drug delivery devices for the administration of 17beta -oestradiol precursors
AU3909597A (en) Dosage form for providing ascending dose of drug
NZ298769A (en) use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception
GB9601969D0 (en) A system for the delivery of drugs and therapeutic agents
ZA94413B (en) Pharmaceutical formulation for the treatment of nicotine dependence
ZA942872B (en) Transdermal therapeutic systems for administering active substances
CA2190837A1 (en) Transdermal delivery of anti-epileptic drugs
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
IL116539A0 (en) Compositions for transdermal delivery of acid-labile drugs
ZA963743B (en) Transdermal therapeutic system (TTS) for the administration of testosterone
GEP20043157B (en) Medicament Against Migraine Recurrence
MX9708557A (es) Nuevo uso farmacologico de los antagonistas del receptor aii.
ZA962752B (en) Rate-controlled transdermal administration of risperidone.
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
ZA96260B (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts
AU4391196A (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
AU3723695A (en) Transdermal device for delivery of levonorgestrel
SI0859595T1 (en) Therapeutic preparation for the transdermal administration of active substances
GB9218422D0 (en) Device for administering single doses of medicament
MX9710002A (es) Nuevo uso medico.
IL137496A0 (en) Dosage form and pharmaceutical kit for increasing the oral availablity of pharmaceutical agents

Legal Events

Date Code Title Description
FA Abandonment or withdrawal